KAZ-12359-51795
4 vaccinations
2 coded responses
27 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 277 / NC
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AZQ-90019-56890
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
-
2021-03-30
Dose 2 — Pfizer-BioNTech
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-22
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-06-29
- 2021-09-28
-
2021-10-21
Dose 3 — Pfizer-BioNTech
- 2022-04-01
-
2022-05-02
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
-
2022-08-01
Survey response — 3 months, dose 4MedDRA: Cough, Headache, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headache sore throat coughMedDRA releases: 2024-11 · check-in free text available
-
2022-08-01
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-02
-
2022-10-31
Survey response — 6 months, dose 4MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: RSVMedDRA releases: 2024-11 · check-in free text available
- 2023-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-05-02 | Pfizer-BioNTech | Tetanus |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 3 months, dose 4
Symptoms: Headache sore throat cough
Release 12 — 6 months, dose 4
Symptoms: RSV
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release